| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |